Compassionate Care Act of 2014
Patients with cancer or a condition that causes chronic seizures or chronic muscle spasms may qualify to receive low-THC cannabis. Low-THC cannabis has very low amounts of the psychoactive ingredient THC and does not usually produce the “high” commonly associated with cannabis.
Florida State patients suffering from ailments listed below are considered eligible for Medical Cannabis:
If a patient is suffering from a terminal condition, as determined by two physicians, the patient may qualify for medical cannabis. This product can contain sufficient levels of the psychoactive ingredient THC to produce the “high” commonly associated with cannabis.
Trulieve (Stage 3-Dispensing)
Surterra Therapeutics (Stage 3-Dispensing)
Modern Health Concepts (Stage 3-Dispensing)
CHT (Stage 1 Cultivation)
The Green Solution (Stage 1 Cultivation)
Knox Medical (Stage 1 Cultivation)
*As Florida approves more Dispensaries this list will be updated to reflect additons
Dispensaries have begun dispensing low-THC products and Medical Cannabis products. For patients with for cancer and epilepsy, products must be more than 10% CBD and less than .8% THC. More than .8% THC is allowed only for terminal illnesses, but this very limited provision currently lacks workable mechanisms for implementation.
Only oil and derivative products are sold – no smoking is allowed (though vaporizing is ok). Florida will be voting on a more expansive medical program in Nov. 2016.
1. Cultivation Authorization
2. Processing Authorization
3. Dispensing Authorization
Florida Medical Marijuana is coming up on the November ballot. November 8th will decide to either amend the existing laws or to remain the same.
Bi-weekly Updates from Dept. of Health
(Last updated: Oct. 19th, 2016)